Chardan Healthcare Acquisition Corp. Contracts & Agreements

Form of Restricted Stock Unit Agreement under the Company's 2019 Omnibus Long-Term Incentive Plan (Filed With SEC on November 14, 2024)

Amended and Restated Chardan Healthcare Acquisition Corp. Long-Term Incentive Plan (Filed With SEC on July 9, 2024)

Form of Indemnification Agreement (Filed With SEC on May 20, 2024)

Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on April 4, 2024)

Form of Indemnification Agreement (Filed With SEC on April 4, 2024)

Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy, dated March 16, 2017 (Filed With SEC on April 4, 2024)

First Amendment, dated January 10, 2019, to Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy (Filed With SEC on April 4, 2024)

Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research, dated August 24, 2021 (Filed With SEC on April 4, 2024)

License Modification 1, dated August 31, 2022, to Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research (Filed With SEC on April 4, 2024)

Lease Agreement, dated as of August 9, 2019, by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 1, dated as of October 28, 2020, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 2, dated as of July 8, 2021, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 3, dated as of July 15, 2021, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 4, dated as of September 27, 2022, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 5, dated as of February 2, 2023, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Amendment No. 6, dated as of March 5, 2024, to Lease Agreement by and between ARE-708 Quince Orchard, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on April 4, 2024)

Form of Warrant (Filed With SEC on March 18, 2024)

Agreement and Plan of Merger, dated March 6, 2024, by and among BiomX Inc., BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc (Filed With SEC on March 6, 2024)

Form of Merger Warrant (Filed With SEC on March 6, 2024)

Form of Private Placement Warrant (Filed With SEC on March 6, 2024)

Form of Placement Agent Warrant (Filed With SEC on March 6, 2024)

Securities Purchase Agreement, dated as of March 6, 2024, by and among BiomX Inc. and each purchaser identified on Annex A thereto (Filed With SEC on March 6, 2024)

Form of Registration Rights Agreement, dated as of March 6, 2024, by and among the Company and certain purchasers (Filed With SEC on March 6, 2024)

Form of Indemnification Agreement (Filed With SEC on November 14, 2023)

Form of Indemnification Agreement (Filed With SEC on May 15, 2023)

Form of Pre-Funded Warrant (Filed With SEC on February 27, 2023)

Form of Pre-Funded Warrant (Filed With SEC on February 22, 2023)

Form of Securities Purchase Agreement dated February 22, 2023 (Filed With SEC on February 22, 2023)

Form of Registration Rights Agreement (Filed With SEC on February 22, 2023)

Loan and Security Agreement dated August 16, 2021 by and among BiomX, Inc., BiomX Ltd., RondinX Ltd. and Hercules Capital, Inc (Filed With SEC on August 16, 2021)

Form of Warrant (Filed With SEC on July 26, 2021)

Form of Securities Purchase Agreement, among BiomX Inc. and the Purchasers named therein (Filed With SEC on July 26, 2021)

Placement Agency Agreement, among BiomX Inc., Cantor Fitzgerald & Co., and Chardan Capital Markets LLC, dated July 26, 2021 (Filed With SEC on July 26, 2021)

An addendum to a lease agreement dated from May 25, 2017, dated September 7, 2020 by and among AFI Assets Ltd., AF SHAR Ltd., WIS and BiomX Ltd. (translated from Hebrew) (Filed With SEC on March 31, 2021)

A lease agreement dated September 7, 2020 by and among AFI Assets Ltd., AF SHAR Ltd., WIS, Nova Measuring Systems Ltd. and BiomX Ltd. (translated from Hebrew) (Filed With SEC on March 31, 2021)

Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2021)

Form of Indemnification Agreement (Filed With SEC on November 12, 2020)

Form of Non-Qualified Stock Option Agreement (U.S. Awards to Non-Executives) (Filed With SEC on March 26, 2020)

Form of Non-Qualified Stock Option Agreement (U.S. Awards to Executive Officers) (Filed With SEC on March 26, 2020)

Form of Option Agreement (Israeli Awards) (Filed With SEC on March 26, 2020)

Waiver Letter to Voting Agreement (Filed With SEC on November 4, 2019)

Registration Rights Agreement dated October 28, 2019 (Filed With SEC on November 1, 2019)

Escrow Agreement dated October 28, 2019, among Chardan Healthcare Acquisition Corp., Shareholder Representative Services LLC and Continental Stock Transfer & Trust Company (Filed With SEC on November 1, 2019)

Voting Agreement dated October 28, 2019 (Filed With SEC on November 1, 2019)

Form of Indemnification Agreement with each director and officer (Filed With SEC on November 1, 2019)

Research and License Agreement, dated June 22, 2015, between BiomX Ltd. and Yeda Research and Development Company Limited, as amended (Filed With SEC on November 1, 2019)

Exclusive Patent License Agreement dated April 25, 2017, between BiomX Ltd. and the Massachusetts Institute of Technology (Filed With SEC on November 1, 2019)

Exclusive Patent License Agreement, dated December 15, 2017, among BiomX Ltd., Keio University and JSR Corporation, as amended (Filed With SEC on November 1, 2019)

Exclusive Patent License Agreement, dated April 22, 2019, among BiomX Ltd., Keio University and JSR Corporation (Filed With SEC on November 1, 2019)

Share Purchase Agreement, dated November 19, 2017, among BiomX Ltd., RondinX Ltd. and Guy Harmelin, as the Shareholders Representative (Filed With SEC on November 1, 2019)

Chardan Healthcare Acquisition Corp. 2019 Equity Incentive Plan (Filed With SEC on November 1, 2019)

Waiver Agreement, dated October 28, 2019 (Filed With SEC on November 1, 2019)

Purchase Agreement, dated October 28, 2019, between Cornix LLC and Chardan Healthcare Acquisition Corp (Filed With SEC on November 1, 2019)

Promissory Note dated October 21, 2019 (Filed With SEC on October 21, 2019)

Amendment Agreement, dated as of October 11, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd., and BiomX Ltd (Filed With SEC on October 15, 2019)

Amendment Agreement, dated as of October 11, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd., and BiomX Ltd (Filed With SEC on October 11, 2019)

Merger Agreement, dated as of July 16, 2019, by and among Chardan Healthcare Acquisition Corp., CHAC Merger Sub Ltd. and BiomX Ltd (Filed With SEC on July 17, 2019)

Underwriting Agreement, dated December 13, 2018, by and between the Registrant and Chardan Capital Markets, LLC (Filed With SEC on December 19, 2018)

Warrant Agreement, dated December 13, 2018, by and between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 19, 2018)

Letter Agreements by and between the Registrant and each of the initial stockholders, officers and directors of the Registrant (Filed With SEC on December 19, 2018)

Investment Management Trust Agreement, dated December 13, 2018, by and between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 19, 2018)

Stock Escrow Agreement, dated December 13, 2018, among the Registrant, Continental Stock Transfer & Trust Company and the initial stockholders (Filed With SEC on December 19, 2018)

Registration Rights Agreement, dated December 13, 2018, among the Registrant, Continental Stock Transfer & Trust Company and the initial stockholders (Filed With SEC on December 19, 2018)

Promissory Note dated December 18, 2018 (Filed With SEC on December 19, 2018)

Form of Underwriting Agreement (Filed With SEC on December 4, 2018)

Specimen Unit Certificate (Filed With SEC on December 4, 2018)

Specimen Common Stock Certificate (Filed With SEC on December 4, 2018)

Specimen Warrant Certificate (Filed With SEC on December 4, 2018)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 4, 2018)

Form of Letter Agreement among the Registrant, Chardan and the Companys officers, directors and stockholders (Filed With SEC on December 4, 2018)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 4, 2018)

Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (Filed With SEC on December 4, 2018)

Form of Registration Rights Agreement among the Registrant and the Initial Stockholders and Continental Stock Transfer & Trust Company (Filed With SEC on December 4, 2018)

Form of Subscription Agreement among the Registrant, the Initial Stockholders and Chardan (Filed With SEC on December 4, 2018)

Category

Industry

Companies

Contracts

Chardan Healthcare Acquisition Corp. Contracts & Agreements